<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03831347</url>
  </required_header>
  <id_info>
    <org_study_id>THRIVE-2</org_study_id>
    <secondary_id>R34AT009886</secondary_id>
    <nct_id>NCT03831347</nct_id>
  </id_info>
  <brief_title>Treatments for Improving Mood in Depressed Teens-2</brief_title>
  <acronym>TeenThrive</acronym>
  <official_title>Adaptation and Pilot Study of Yoga to Reduce Depression in Adolescents</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brown University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Butler Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Center for Complementary and Integrative Health (NCCIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Brown University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Phase 2: Open Trial N=12 adolescents will be enrolled into a single-arm pilot trial to test&#xD;
      the adapted hatha yoga intervention&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In Phase 2, the investigators will conduct an open single-arm pilot trial of our 12 week&#xD;
      adapted hatha yoga intervention.&#xD;
&#xD;
      the investigators will enroll 12 adolescents in the open pilot trial.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2019</start_date>
  <completion_date type="Actual">August 29, 2019</completion_date>
  <primary_completion_date type="Actual">August 14, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Qualitative interview</measure>
    <time_frame>Post intervention (month 3)</time_frame>
    <description>Acceptability assessed with Qualitative interview</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Credibility Expectancy Questionnaire (CEQ) - Credibility subscale</measure>
    <time_frame>Week 1</time_frame>
    <description>Credibility assessed with Credibility Expectancy Questionnaire (CEQ), credibility subscale. The credibility subscale of the CEQ, is a 3 item subscale of the 6 item CEQ. The 3 items are measured on a 1-9 scale (not at all - very), Higher scores indicate greater credibility.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Credibility Expectancy Questionnaire (CEQ) - Expectancy subscale</measure>
    <time_frame>Week 1</time_frame>
    <description>Patient expectations assessed with the Credibility Expectancy Questionnaire (CEQ), expectancy subscale. The expectancy subscale is a 3 item subscale of the 6 item CEQ. One of the 3 items are measured on a 1-9 scale (not at all - very), 2 are on a 0-10 scale (0-100%). Higher scores indicate greater expectations.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The Client Satisfaction Questionnaire (CSQ-8)</measure>
    <time_frame>Post intervention (month 3)</time_frame>
    <description>Satisfaction with treatment assessed with The Client Satisfaction Questionnaire (CSQ-8). The CSQ-8 is an 8-item measure with each item measured on a 1-4 scale. Higher scores indicate greater client satisfaction.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Home practice questionnaire</measure>
    <time_frame>Post intervention (month 3)</time_frame>
    <description>Yoga home practice assessed with a Home practice questionnaire. Duration, frequency, and type of formal and informal home yoga practice between class sessions.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Systematic assessment of treatment-emergent events-general inquiry (SAFTEE)</measure>
    <time_frame>Post intervention (month 3)</time_frame>
    <description>Participant safety/adverse events will be measured using the SAFTEE. Participants will also be asked weekly if they experienced any injuries as a result of yoga.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quick Inventory of Depression - Adolescent Version - Clinician Rating (QIDS-A-CR)</measure>
    <time_frame>From baseline to post intervention (month 3)</time_frame>
    <description>Change in depression symptom severity will be assessed using the QIDS. The QIDS is a 17 item measure with scores ranging from 0-30. Higher scores indicate greater depressive symptoms.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">11</enrollment>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>Hatha Yoga</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>12 weeks of modified Hatha Yoga specifically designed to be administered to teens with depression.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Hatha Yoga</intervention_name>
    <description>12 weeks of Hatha Yoga</description>
    <arm_group_label>Hatha Yoga</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Adolescents must have elevated depressive symptoms, defined by a score of 11 or higher&#xD;
             on the Quick Inventory of Depression -Adolescent Version-- Clinician Rating&#xD;
             (QIDS-A-CR), including endorsement of either sad mood or anhedonia on the QIDS.&#xD;
&#xD;
          2. Other treatment for depression must be stable at baseline. Adolescents do not have to&#xD;
             be in other treatment for depression, but, if they are, it must be stable for the past&#xD;
             12 weeks.&#xD;
&#xD;
          3. Adolescents must be aged 13-18.&#xD;
&#xD;
          4. Adolescents must be medically cleared for moderate physical activity by their primary&#xD;
             care physician. This criterion may be met by a current (dated in the past year)&#xD;
             statement from their pediatrician that the adolescent may participate in school or&#xD;
             camp programs including physical education.&#xD;
&#xD;
          5. Adolescents must be able to read and write English sufficient to complete informed&#xD;
             consent and engage in interventions.&#xD;
&#xD;
          6. Adolescents aged 13-17 must assent to be in the study, and their parent or legal&#xD;
             guardian must consent to their participation. Adolescents aged 18 must consent to be&#xD;
             in the study.&#xD;
&#xD;
          7. Able to attend one of the class times.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. QIDS- A-CR may not be higher than a score of 21. This ensures that adolescents are not&#xD;
             severely depressed.&#xD;
&#xD;
          2. Adolescents who meet criteria for:&#xD;
&#xD;
               -  Current (past year) autism spectrum disorder (AS), if of sufficient severity to&#xD;
                  interfere with study treatment per clinician judgment;&#xD;
&#xD;
               -  Schizophrenia;&#xD;
&#xD;
               -  Bipolar disorder;&#xD;
&#xD;
               -  Clinically significant psychotic symptoms in the past month;&#xD;
&#xD;
               -  Anorexia or Bulimia in past 3 months&#xD;
&#xD;
               -  Substance use disorders in the past 12 months and symptoms are of sufficient&#xD;
                  severity to interfere with study treatment per clinician judgment These will be&#xD;
                  assessed with the Mini-International Neuropsychiatric Interview (MINI).&#xD;
&#xD;
          3. Adolescents may not have current suicide ideation or behavior that warrants immediate&#xD;
             treatment. They may have passive ideation (i.e., thoughts that life is not worth&#xD;
             living), but may not have active suicide ideation, intent, plan, or an attempt within&#xD;
             the previous 6 months.&#xD;
&#xD;
          4. Adolescents cannot currently be engaged in or yoga classes, as this is the study&#xD;
             intervention.&#xD;
&#xD;
          5. Adolescents cannot be pregnant as yoga should be modified for pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lisa Uebelacker, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Butler Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Shirley Yen, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brown University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Butler Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02906</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 30, 2019</study_first_submitted>
  <study_first_submitted_qc>February 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 5, 2019</study_first_posted>
  <last_update_submitted>January 28, 2021</last_update_submitted>
  <last_update_submitted_qc>January 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All IPD underlying publication if required by journal.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>One year after study collection.</ipd_time_frame>
    <ipd_access_criteria>Information available upon request, please send to PIs Lisa Uebelacker or Shirley Yen.</ipd_access_criteria>
  </patient_data>
  <pending_results>
    <submitted>October 26, 2021</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

